CH620927A5 - Process for the preparation of 3-alkyl-7-oxoalkylxanthines - Google Patents

Process for the preparation of 3-alkyl-7-oxoalkylxanthines Download PDF

Info

Publication number
CH620927A5
CH620927A5 CH1561475A CH1561475A CH620927A5 CH 620927 A5 CH620927 A5 CH 620927A5 CH 1561475 A CH1561475 A CH 1561475A CH 1561475 A CH1561475 A CH 1561475A CH 620927 A5 CH620927 A5 CH 620927A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
alkyl
water
shark
oxoalkylxanthines
Prior art date
Application number
CH1561475A
Other languages
German (de)
English (en)
Inventor
Werner Dr Mohler
Manfred Dr Jayme
Jaromir Dr Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH620927A5 publication Critical patent/CH620927A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH1561475A 1974-12-06 1975-12-02 Process for the preparation of 3-alkyl-7-oxoalkylxanthines CH620927A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742457666 DE2457666A1 (de) 1974-12-06 1974-12-06 Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine

Publications (1)

Publication Number Publication Date
CH620927A5 true CH620927A5 (en) 1980-12-31

Family

ID=5932662

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1561475A CH620927A5 (en) 1974-12-06 1975-12-02 Process for the preparation of 3-alkyl-7-oxoalkylxanthines
CH18480A CH622520A5 (en) 1974-12-06 1980-01-10 Process for the preparation of novel 3-alkyl-7-oxoalkylxanthines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH18480A CH622520A5 (en) 1974-12-06 1980-01-10 Process for the preparation of novel 3-alkyl-7-oxoalkylxanthines

Country Status (15)

Country Link
JP (1) JPS5182296A (xx)
AT (1) AT346362B (xx)
AU (1) AU496825B2 (xx)
BE (1) BE835521A (xx)
CH (2) CH620927A5 (xx)
DE (1) DE2457666A1 (xx)
DK (1) DK550775A (xx)
ES (1) ES442837A2 (xx)
FI (1) FI753435A (xx)
FR (1) FR2293205A2 (xx)
GB (1) GB1533866A (xx)
NL (1) NL7514243A (xx)
NO (1) NO143706C (xx)
SE (1) SE7513759L (xx)
ZA (1) ZA757303B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (xx) * 1974-01-22 1978-12-29 Wuelfing J A Fa
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
BE835521A (fr) 1976-03-01
AU496825B2 (en) 1978-11-02
CH622520A5 (en) 1981-04-15
SE7513759L (sv) 1976-06-08
DE2457666A1 (de) 1976-06-10
ATA486877A (de) 1978-03-15
FI753435A (xx) 1976-06-07
NO143706B (no) 1980-12-22
NO753806L (xx) 1976-06-09
FR2293205A2 (fr) 1976-07-02
FR2293205B2 (xx) 1978-08-25
JPS5182296A (en) 1976-07-19
ES442837A2 (es) 1977-05-16
NL7514243A (nl) 1976-06-09
NO143706C (no) 1981-04-01
AU8711575A (en) 1977-06-02
ZA757303B (en) 1976-11-24
GB1533866A (en) 1978-11-29
AT346362B (de) 1978-11-10
DK550775A (da) 1976-06-07

Similar Documents

Publication Publication Date Title
DE2330742C2 (de) 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE3028273C2 (xx)
EP0044940A1 (de) Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
EP0053767A1 (de) Tricyclische Cytosinderivate zur Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
DE2714953C2 (de) Arzneimittel
DE1815808B2 (de) 1 -(Alkanoylamiitophenoxy)-3-alkylamino-2-propanole deren Herstellungsverfahren und pharmazeutische Zusammensetzungen auf deren Basis
CH620927A5 (en) Process for the preparation of 3-alkyl-7-oxoalkylxanthines
DE3028272C2 (xx)
EP0018360A1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung.
DE1965711C3 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1545772B1 (de) 7-(3'-Picolylamino-alkyl)-theophylline und deren nikotinsaure Salze
AT344727B (de) Verfahren zur herstellung von neuen 3-alkyl-7- (omega-1)-oxoalkylxanthinen
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
DE3019019C2 (xx)
DE924632C (de) Verfahren zur Herstellung von Dialkylxanthinabkoemmlingen
AT334392B (de) Verfahren zur herstellung von neuen 1- oder 7-(omega-1)-oxoalkyl-3,7 (oder 1,3-)-dialkylxanthinen
AT334391B (de) Verfahren zur herstellung von neuen 1- oder 7-(omega-1)-oxoalkyl-3,7-(oder 1,3-)dialkylxanthinen
AT333301B (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
AT359524B (de) Verfahren zur herstellung von neuen mono-oder di-alkenylxanthinen
AT333302B (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
DE2366501C2 (de) 1-Alkyl-3-methyl-7-oxoalkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AT333303B (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
DE1915979C3 (de) 1,3-Dimethyl-xanthin-Derivate und Verfahren zu ihrer Herstellung
DE2708827A1 (de) Substituierte purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische zubereitungen

Legal Events

Date Code Title Description
PL Patent ceased